Friday, July 10, 2026

pharma · Myelofibrosis · Myelodysplastic syndromes (MDS)

Geron Netherlands

News and analysis for Geron Netherlands on NovaPharmaNews — regulatory, clinical, and market coverage.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
3
Drugs
2
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Geron Netherlands — regulatory, clinical, and market coverage.

News and analysis for Geron Netherlands on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Geron Netherlands yet.

Back to company overview →